Skip to main content
Tue, Apr 7, 2026
TrendingNews.today
World News
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
S&P 500 5,142.30 ▲ +0.87%|NASDAQ 16,284.75 ▲ +1.12%|DOW 38,972.10 ▼ -0.23%|AAPL $192.45 ▲ +1.80%|TSLA $241.80 ▼ -2.10%|AMZN $178.92 ▲ +0.54%|GOOGL $141.20 ▲ +0.32%|MSFT $415.60 ▼ -0.15%|
Sample data
BusinessUnited States1 sourcesNeutral

Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

VYKAT™ XR (diazoxide choline) is the First and Only FDA Approved Treatment for Hyperphagia in Prader-Willi Syndrome and Represents a Transformative Therapy...

PR Newswire
via PR Newswire
ShareRead original

Read the full article at PR Newswire →

Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

Source Verification

Corroboration Score: 1

This story was independently reported by 1 sources. Click any source to read the original article.

PR Newswire
PR Newswire
GNewsUS

Comments

0 comments
Be respectful and constructive.
Loading comments...
Previous
Paediatric nurse arrested for 'possessing and selling' sick child abuse videos
Next
Mayor Brandon Johnson angles for CHA control amid city agency turmoil

Related Articles

Mass. cannabis reforms approved by legislative committeeBusiness
Mass. cannabis reforms approved by legislative committee
Bryan Hecht-4h ago-1 sources
Drone Incursions Over U.S. Bases Raise Security Concerns As Iran Tensions EscalateBusiness
Drone Incursions Over U.S. Bases Raise Security Concerns As Iran Tensions Escalate
Merin Rebecca Thomas-4h ago-1 sources
Why FuboTV Stock Popped TodayBusiness
Why FuboTV Stock Popped Today
Joe Tenebruso-4h ago-1 sources